| Typicality: | 0.421 |
| Saliency: | 0.402 |
| including avelumab | 3 | other |
| antibody → target → pd-l1 | 13 |
| antibody → bind to → pd-l1 | 4 |
| antibody → target → human pd-l1 | 4 |
| antibody → target → the pd-1/pd-l1 axis | 3 |
| negative | neutral | positive |
| 0.081 | 0.517 | 0.401 |
| Raw frequency | 24 |
| Normalized frequency | 0.402 |
| Modifier score | 0.500 |
| Perplexity | 93.480 |